Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA-CD vaccine versus placebo for cocaine dependence
2008-002183-34Phase 2Terminated
- Sponsor
- Celtic Pharma
- Start
- Sep 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine use disorder (CUD) comparing TA-CD with Placebo (2 arms). Primary endpoint: Clinical efficacy during weeks 9 to 16. Started Sep 2008; status: terminated.
02
Drugs
TA-CD
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on 2008-002183-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002183-34.